Alsugair A, Fathima S, Aperna F, Gangat N, Tefferi A. Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. haematol [Internet]. 2020Sep.10 [cited 2025Feb.1];. Available from: https://haematologica.org/article/view/11914